Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
Vasiliki Liakouli, Antonio Ciancio, Francesco Del Galdo, et al.
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 1, pp. 21-32
Closed Access | Times Cited: 16

Showing 16 citing articles:

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort
Eliane Roth, Cosimo Bruni, L. Petelytska, et al.
Lara D. Veeken (2025)
Closed Access
Personalized Medicine for Systemic Sclerosis-Associated Interstitial Lung Disease
Angela Ma, Sydney B. Montesi
Current Treatment Options in Rheumatology (2025) Vol. 11, Iss. 1
Closed Access
Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic and inflammation pathways
Carlos Rosa-Baez, Gonzalo Borrego‐Yaniz, Inmaculada Rodríguez-Martín, et al.
Lara D. Veeken (2025)
Closed Access
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis
Leslie A. Nangle, Zhiwen Xu, David Siefker, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 789
Closed Access
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis
M. Martel, Amélie Leurs, David Launay, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 5, pp. 103536-103536
Open Access | Times Cited: 3
Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling
Na Tian, Hao Cheng, Yu Du, et al.
Journal of Autoimmunity (2024) Vol. 147, pp. 103233-103233
Closed Access | Times Cited: 3
Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics
Mirza Salman Baig, Anas Ahmad, Rijawan Rajjak Pathan, et al.
Journal of Xenobiotics (2024) Vol. 14, Iss. 3, pp. 827-872
Open Access | Times Cited: 3
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)
Vasiliki Liakouli, Ignazio Verde, Piero Ruscitti, et al.
Clinical and Experimental Rheumatology (2024)
Closed Access | Times Cited: 1
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease
Emanuele Gotelli, Stefano Soldano, Carol Feghali‐Bostwick, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Low Carbon Monoxide Diffusing Capacity, Patient-Reported Measures and Reduced Nailfold Capillary Density Are Associated with Interstitial Lung Disease in Systemic Sclerosis
Rossella De Angelis, Edoardo Cipolletta, Francesca Francioso, et al.
(2024)
Open Access | Times Cited: 1
Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features
Jing Zhao, Ying Long, Shengtao Li, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 2027-2041
Open Access | Times Cited: 1
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions
Ying-Xian Dong, Sicheng Zhou, Jie Tian
Autoimmunity Reviews (2024) Vol. 24, Iss. 1, pp. 103697-103697
Closed Access | Times Cited: 1
Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis
Takuya Takahashi, Takehiro Takahashi, Tetsuya Ikawa, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 8, pp. 1083-1090
Closed Access
Risk Factors for Interstitial Lung Disease in Patients with Systemic Sclerosis: A Meta-Analysis
昕 齐
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 2665-2673
Closed Access
Low-Carbon Monoxide Diffusing Capacity, Patient-Reported Measures and Reduced Nailfold Capillary Density Are Associated with Interstitial Lung Disease in Systemic Sclerosis
Rossella De Angelis, Edoardo Cipolletta, Francesca Francioso, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 635-635
Open Access
Managing Symptoms of Systemic Sclerosis for the Allergist-Immunologist
Mehreen Elahee, Robyn T. Domsic
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 8, pp. 433-441
Closed Access
Page 1

Scroll to top